As of April 19, 2025, Fractyl Health (GUTS) has a market cap of $59.683 million USD. According to our data, Fractyl Health is ranked No.7948 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $59.68 M |
-39.77%
|
Dec 31, 2024 | $99.08 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() DexCom
DXCM
|
$26.89 B |
-0.001 M
|
![]() USA
|
![]() Medtronic
MDT
|
$105.94 B |
0.001 M
|
![]() Ireland
|
![]() Insulet
PODD
|
$17.33 B |
-0.001 M
|
![]() USA
|
![]() Tandem Diabetes Care
TNDM
|
$1.12 B |
0.000 M
|
![]() USA
|
![]() Abbott Laboratories
ABT
|
$227.16 B |
0.001 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$285.37 B |
89.978 B
|
![]() Denmark
|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Becton Dickinson
BDX
|
$57.06 B |
0.001 M
|
![]() USA
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
Market Cap | = | GUTS Stock Price | * | GUTS Shares Outstanding |
= | $1.22 | * | 48.92 M | |
= | $59.68 M |